Is BaF3 Bioassay Useful to Identify Patients with Bioinactive Growth Hormone?

被引:2
|
作者
Pagani, Sara [1 ]
Chaler, Eduardo A. [2 ]
Meazza, Cristina [1 ]
Maceiras, Mercedes [2 ]
Gonzalez, Maria Eugenia [2 ]
Rivarola, Marco A. [2 ]
Cantoni, Francesca [1 ]
Travaglino, Paola [1 ]
Della Croce, Lucia [3 ]
Laarej, Kamilia [1 ]
Bozzola, Mauro [1 ]
Belgorosky, Alicia [2 ]
机构
[1] Univ Pavia, Dept Pediat, I-27100 Pavia, Italy
[2] Garrahan Pediat Hosp, Endocrinol Lab, Buenos Aires, DF, Argentina
[3] Univ Pavia, Dept Math, I-27100 Pavia, Italy
来源
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM | 2010年 / 23卷 / 08期
关键词
growth hormone; bioassay; gene mutation; cell line; GH biological activity; SHORT STATURE; GH DEFICIENCY; GENE MUTATION; HUMAN-SERUM; BIOACTIVITY; CHILDREN; ASSAY; FAILURE; SECRETION; TESTS;
D O I
10.1515/jpem.2010.128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We analyzed the ability of the BaF3 cell line bioassay to select patients with biologically inactive GH. We first evaluated the biological response of the Ba/F3-hGHR cells to rhGH additional doses from 10 to 5000 pg/ml. The concentration points corresponding to the linear part of the curve were selected. We then analyzed a group of sera, diluted like the standard, including the entire range of GH concentrations that can be analyzed by bioassay. The serum/standard area below the curve ratio was calculated. Serum GH immunoactivity determined by IMMULITE/GH bioactivity ratios was calculated. Our experimental data showed that GH-bioactivity/GH-immunoactivity ratios below 0.303 are indicative of a bioinactive GH molecule. This bioassay would recognize only extreme cases of GH bioinactivity, and it would not be a useful tool in the search for patients with altered forms of GH.
引用
收藏
页码:783 / 788
页数:6
相关论文
共 50 条
  • [41] Effect of GH and IGF-1 therapy in 3 patients with growth hormone insensitivity (GHI) due to mutation of the GH receptor gene
    Basit, Nauman
    Sinha, Sunil K.
    Ten, Svetlana
    Bhangoo, Amrit
    HORMONE RESEARCH, 2008, 70 : 99 - 99
  • [42] Elevated growth hormone and leptin serum levels with normal IGF-1/GFBP-3 axis in rheumatoid arthritis patients
    Toussirot, E
    Nguyen, NU
    Dumoulin, G
    Aubin, F
    Cedoz, JP
    Wendling, D
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 176 - 177
  • [43] The identification of cerebral volume changes in treated growth hormone deficient patients using serial 3-D MR image processing
    Denton, ER
    Holden, M
    Jarosz, JM
    Studholme, C
    Cox, TC
    Hill, DL
    RADIOLOGY, 1998, 209P : 472 - 472
  • [44] Growth hormone (GH) pharmacogenetics: Influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency
    Jorge, AAL
    Marchisotti, FG
    Montenegro, LR
    Carvalho, LR
    Mendonca, BB
    Arnhold, IJP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03): : 1076 - 1080
  • [45] ADJUVANT RECOMBINANT HUMAN GROWTH-HORMONE STIMULATES INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 SECRETION IN CRITICALLY ILL TRAUMA PATIENTS
    PETERSEN, SR
    JEEVANANDAM, M
    HOLADAY, NJ
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1995, 39 (02): : 295 - 302
  • [46] INFLUENCE OF HUMAN GROWTH-HORMONE (HGH) ON THE THYROXINE (T4)-TRIIODOTHYRONINE (T3)-RATIO IN HGH DEFICIENT PATIENTS
    STOLECKE, H
    ANDLER, W
    PEDIATRIC RESEARCH, 1979, 13 (10) : 1193 - 1193
  • [47] EVALUATION OF 7 PATIENTS FROM 3 FAMILIES WITH ISOLATED GROWTH HORMONE DEFICIENCY DUE TO TWO DIFFERENT GHRHR GENE FUNCTION LOSS MUTATIONS
    Kurnaz, Erdal
    Erdeve, Senay Savas
    Legendre, Marie
    Bayramoglu, Elvan
    Sahin, Nursel Muratoglu
    Keskin, Meliksah
    Cetinkaya, Semra
    Aycan, Zehra
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 310 - 310
  • [48] PLASMA 3-METHOXY-4-HYDROXYPHENYLETHYLENE GLYCOL (MHPG) AND GROWTH-HORMONE RESPONSES TO YOHIMBINE IN PANIC DISORDER PATIENTS AND NORMAL CONTROLS
    GURGUIS, GNM
    UHDE, TW
    PSYCHONEUROENDOCRINOLOGY, 1990, 15 (03) : 217 - 224
  • [49] Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with β-thalassaemia major and the effect of GH treatment
    Low, LCK
    Postel-Vinay, MC
    Kwan, EYW
    Cheung, PT
    CLINICAL ENDOCRINOLOGY, 1998, 48 (05) : 641 - 646
  • [50] Elevated growth hormone and leptin serum levels with normal IGF-I IGFBP-3 axis in rheumatoid arthritis patients.
    Toussirot, E
    Nguyen, N
    Dumoulin, G
    Aubin, F
    Cedoz, JP
    Wendling, D
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S496 - S496